Position
Squarepoint Ops LLC in Enanta Pharmaceuticals Inc
Back to the book · All holders of ENTA
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$42.6K$15.77 → $12.63
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 66K | $1.04M | — | — | — | 0.0% |
| Q1 2026 | 13.6K | $171.4K | $12.63 | −$42.6K | −$826.3K | 0.0% |